Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB vs ICATIBANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBRUTINIB vs ICATIBANT: Safety Overview

Metric IBRUTINIB ICATIBANT
Total FAERS Reports 75,087 5,363
Deaths Reported 12,580 234
Death Rate 16.8% 4.4%
Hospitalizations 24,920 2,451
Average Patient Age 71.2 yrs 46.3 yrs
% Female Patients 39.2% 75.0%
FDA Approval Date Aug 24, 2022 Aug 14, 2023
Manufacturer Pharmacyclics LLC Alembic Pharmaceuticals Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription